Gabapentin in partial epilepsy. UK Gabapentin Study Group.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  The Lancet

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1971862
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gabapentin as an antiepileptic drug in man.

  1987cited by this paper
• Early Treatment and Prognosis of Epilepsy

  1987cited by this paper
• A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy.

  1986cited by this paper
• Determination of gabapentin in plasma and urine by high-performance liquid chromatography and pre-column labelling for ultraviolet detection.

  1985cited by this paper
• Two antiepileptic drugs for intractable epilepsy with complex-partial seizures.

  1982cited by this paper
• The two-period cross-over clinical trial.

  1979cited by this paper

• Effectiveness and safety of single anti-seizure medication as adjunctive therapy for drug-resistant focal epilepsy based on network meta-analysis

  2025cites this paper
• Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis

  2024cites this paper
• Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?

  2022cites this paper
• Gabapentin add-on treatment for drug-resistant focal epilepsy.

  2021cites this paper
• Patterns of anticonvulsant use and adverse drug events in older adults

  2020cites this paper
• Gabapentin add-on treatment for drug-resistant focal epilepsy.

  2018cites this paper
• Evaluate the Efficacy and Safety of Anti‐Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta‐Analysis

  2017cites this paper
• Disabling Asterixis Induced By Gabapentin

  2015cites this paper
• Comparative efficacy and tolerability of anti‐epileptic drugs for refractory focal epilepsy: systematic review and network meta‐analysis reveals the need for long term comparator trials

  2013cites this paper
• Investigation of Influencing Factors on Higher Placebo Response in East Asian Versus Western Clinical Trials for Partial Epilepsy: A Meta-Analysis

  2013cites this paper
• Gabapentin add-on for drug-resistant partial epilepsy.

  2013cites this paper
• New drugs for the treatment of epilepsy: a practical approach.

  2013cites this paper
• Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study.

  2012cites this paper
• Costs, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin.

  2012cites this paper
• Clinical development of antiepileptic drugs in adults

  2011cites this paper
• Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta‐analysis

  2011cites this paper
• A Comparison of Different Doses of Gabapentin to Attenuate the Haemodynamic Response to Laryngoscopy and Tracheal Intubation in Normotensive Patients

  2011cites this paper
• New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?

  2011cites this paper
• Empirical Evidence of Associations Between Trial Quality and Effect Size

  2011cites this paper
• Adjunctive antiepileptic drugs in adult epilepsy: how the first add-on could be the last

  2010cites this paper
• Pregabalin versus gabapentin in partial epilepsy: a meta-analysis of dose-response relationships

  2010cites this paper
• A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

  2010cites this paper
• A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures.

  2010cites this paper
• Clinical Perspectives on Lacosamide

  2009cites this paper
• Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers.

  2009cites this paper
• Advancements in the treatment of epilepsy.

  2008cites this paper
• CNS Adverse Events Associated with Antiepileptic Drugs

  2008cites this paper
• Seizure‐Free Outcome in Randomized Add‐on Trials of the New Antiepileptic Drugs

  2007influential citation
• Second-generation antiepileptic drugs' impact on balance: a meta-analysis.

  2007cites this paper
• [A novel antiepileptic, gabapentin (GABAPEN)].

  2007cites this paper
• Seizure aggravation by antiepileptic drugs

  2006cites this paper
• Treatment of partial seizures with gabapentin: Double‐blind, placebo‐controlled, parallel‐group study *

  2006cites this paper
• The Safety and Effectiveness of Newer Antiepileptics: A Comparative Postmarketing Cohort Study

  2005cites this paper
• Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model

  2005cites this paper
• Structural Determinants for Branched-chain Aminotransferase Isozyme-specific Inhibition by the Anticonvulsant Drug Gabapentin*

  2005cites this paper
• Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

  2004cites this paper
• Measuring the efficacy of antiepileptic drugs.

  2003cites this paper
• The absorption of gabapentin following high dose escalation.

  2003cites this paper
• Gabapentin dosing in the treatment of epilepsy.

  2003cites this paper
• Efficacy and Safety of 4‐Aminopyridine in Patients with Long‐Term Spinal Cord Injury: A Randomized, Double‐Blind, Placebo‐Controlled Trial

  2003cites this paper
• A Postmarketing Surveillance Study of Gabapentin as Add‐on Therapy for 3,100 Patients in England

  2002cites this paper
• Antikonvulsive Pharmakotherapie: Entwicklung in den letzten 10 Jahren

  2002cites this paper
• Is gabapentin a "Broad-spectrum" analgesic?

  2002cites this paper
• Efficacy and Safety of Levetiracetam in Children with Partial Seizures: An Open‐label Trial

  2002cites this paper
• Placebos, Placebo Effect, and the Response to the Healing Situation: The Evolution of a Concept

  2001cites this paper
• Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.

  2000cites this paper
• Gabapentin Versus Vigabatrin as First Add‐On for Patients with Partial Seizures That Failed to Respond to Monotherapy: A Randomized, Double‐Blind, Dose Titration Study

  2000cites this paper
• A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.

  2000cites this paper
• New anti-epileptic drugs for the 21st century

  2000cites this paper
• New antiepileptic drugs.

  2000cites this paper
• Choice and Use of Newer Anticonvulsant Drugs in Older Patients

  2000cites this paper
• Gabapentin "add-on therapy" for idiopathic chronic hiccup (ICH).

  2000cites this paper
• Treatment of Epilepsy in the New Millennium

  2000cites this paper
• Adverse Reactions to New Anticonvulsant Drugs

  2000cites this paper
• Treatment of epilepsy in the multiply handicapped.

  2000cites this paper
• Gabapentin for the management of agitation.

  1999cites this paper
• New Antiepileptic Drugs: Comparison of Key Clinical Trials

  1999cites this paper
• Effects of Age and Gender on Single‐Dose Pharmacokinetics of Gabapentin

  1999cites this paper
• Gabapentin as Adjunctive Therapy for Partial Seizures

  1999cites this paper
• Evidence‐based Medicine and Antiepileptic Drugs

  1999cites this paper
• Gabapentin as Add‐On Therapy in Children with Refractory Partial Seizures: A 12‐Week, Multicentre, Double‐Blind, Placebo‐Controlled Study

  1999cites this paper
• Dosing to Efficacy with Neurontin: The STEPS Trial

  1999cites this paper
• Fortnightly review: drug treatment of epilepsy.

  1999cites this paper
• Use of New Antiepileptic Drugs in the Treatment of Childhood Epilepsy

  1999cites this paper
• 3‐Substituted GABA analogs with central nervous system activity: A review

  1999cites this paper
• Monotherapy Trials with Gabapentin for Partial Epilepsy

  1999cites this paper
• Gabapentin in the Management of Convulsive Disorders

  1999cites this paper
• Gabapentin

  1999cites this paper
• Advances in the medical treatment of epilepsy.

  1998cites this paper
• A summary of mechanistic hypotheses of gabapentin pharmacology.

  1998cites this paper
• Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.

  1998cites this paper
• Aggravation of Focal Epileptic Seizures by Antiepileptic Drugs

  1998cites this paper
• High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients.

  1998cites this paper
• Do Antiepileptic Drugs Exacerbate Seizures?

  1998cites this paper
• Conversion to High Dose Gabapentin Monotherapy in Patients with Medically Refractory Partial Epilepsy

  1998cites this paper
• Monotherapy Trials of New Antiepileptic Drugs

  1997cites this paper
• The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability

  1997cites this paper
• Neurochemical actions of gabapentin in mouse brain.

  1997cites this paper
• New antiepileptic drugs in children: present and future.

  1997cites this paper
• Gabapentin for treatment of epilepsy in children.

  1997cites this paper
• Overview of the Safety of Newer Antiepileptic Drugs

  1997cites this paper
• Utility of the Lethargic (lh/lh) Mouse Model of Absence Seizures in Predicting the Effects of Lamotrigine, Vigabatrin, Tiagabine, Gabapentin, and Topiramate Against Human Absence Seizures

  1997cites this paper
• Open label gabapentin treatment for pain in multiple sclerosis

  1997cites this paper
• Gabapentin for behavioral agitation in Alzheimer's disease.

  1997cites this paper
• Clinical Administration of New Antiepileptic Drugs: An Overview of Safety and Efficacy

  1996cites this paper
• New antiepileptic drugs.

  1996cites this paper
• Clinical Pharmacokinetics of Newer Antiepileptic Drugs

  1996cites this paper
• The National Hospital Seizure Severity Scale: A Further Development of the Chalfont Seizure Severity Scale

  1996cites this paper
• Management of chronic pain. Part I.

  1996cites this paper
• Ethical use of placebos and provocative testing in diagnosing nonepileptic seizures

  1996cites this paper
• Drug Treatment of Epilepsy in the 1990s

  1996cites this paper
• The impact of new antiepileptic drugs on the prognosis of epilepsy

  1996cites this paper
• Newer anti-epileptic drugs

  1996cites this paper
• Behavioral Side Effects of Gabapentin in Children

  1996cites this paper
• Current Developments in Neurology, Part I: Advances in the Pharmacotherapy of Headache, Epilepsy, and Multiple Sclerosis

  1996cites this paper
• Clinical Efficacy of New Antiepileptic Drugs in Refractory Partial Epilepsy: Experience in the United States With Three Novel Drugs

  1996cites this paper
• Management of Epilepsy in the Elderly

  1996cites this paper
• Diagnosis and Treatment of Epilepsy in Children and Adolescents

  1996cites this paper
• Gabapentin, valproic acid, and ethanol intoxication: elevated blood levels with mild clinical effects.

  1996cites this paper
• New drugs for the treatment of epilepsy.

  1996cites this paper